Literature DB >> 3808303

A case-control study of smoking habits, dementia, and other illnesses in idiopathic Parkinson's disease.

A H Rajput, K P Offord, C M Beard, L T Kurland.   

Abstract

From 1967 to 1979, 118 incident cases of idiopathic Parkinson's disease (IPD) and 236 age- and sex-matched controls from Rochester, MN, were identified. Medical records on patients and controls for 40 years preceding the diagnosis of IPD were reviewed. The relative risk (RR) for ever-smoked and IPD was not significantly different from unity (RR = 0.7, 95% confidence interval = 0.4 to 1.2). The mean age at diagnosis of IPD was significantly younger (p = 0.007) in the ever-smokers (68.8 years) compared with never-smokers (73.8 years), although this needs to be interpreted cautiously. It is concluded that smoking had no effect on the development of IPD. Within 5 years after the index date, a new diagnosis of dementia was made more often in cases than in controls (p = 0.01). Relative risk of IPD significantly increased when prior diagnosis of psychoneurosis and psychosomatic illness had been made.

Entities:  

Mesh:

Year:  1987        PMID: 3808303     DOI: 10.1212/wnl.37.2.226

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  15 in total

1.  The sydney multicentre study of Parkinson's disease: progression and mortality at 10 years.

Authors:  M A Hely; J G Morris; R Traficante; W G Reid; D J O'Sullivan; P M Williamson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-09       Impact factor: 10.154

Review 2.  How far are we in understanding the cause of Parkinson's disease?

Authors:  Y Ben-Shlomo
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-07       Impact factor: 10.154

3.  Neuropsychological prediction of dementia in Parkinson's disease.

Authors:  F Mahieux; G Fénelon; A Flahault; M J Manifacier; D Michelet; F Boller
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-02       Impact factor: 10.154

Review 4.  Hypothesis: a nicotine-dopamine interaction linking smoking with Parkinson's disease and tardive dyskinesia.

Authors:  D G Kirch; A M Alho; R J Wyatt
Journal:  Cell Mol Neurobiol       Date:  1988-09       Impact factor: 5.046

5.  Clinical characteristics in early Parkinson's disease in a central California population-based study.

Authors:  Gail A Kang; Jeff M Bronstein; Donna L Masterman; Matthew Redelings; Jarrod A Crum; Beate Ritz
Journal:  Mov Disord       Date:  2005-09       Impact factor: 10.338

Review 6.  Nicotinic receptor mechanisms and cognition in normal states and neuropsychiatric disorders.

Authors:  Kristi A Sacco; Katie L Bannon; Tony P George
Journal:  J Psychopharmacol       Date:  2004-12       Impact factor: 4.153

7.  Parkinson's disease and CYP1A2 activity.

Authors:  J T Forsyth; R A Grünewald; A Rostami-Hodjegan; M S Lennard; H J Sagar; G T Tucker
Journal:  Br J Clin Pharmacol       Date:  2000-10       Impact factor: 4.335

8.  Cost effectiveness of treatment of Parkinson's disease with entacapone in the United States.

Authors:  Cynthia S Palmer; Mark J C Nuijten; Jordana K Schmier; Prasun Subedi; Edward H Snyder
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

Review 9.  Genetic and environmental aspects of the role of nicotinic receptors in neurodegenerative disorders: emphasis on Alzheimer's disease and Parkinson's disease.

Authors:  J R James; A Nordberg
Journal:  Behav Genet       Date:  1995-03       Impact factor: 2.805

10.  Cancers Preceding Parkinson's Disease after Adjustment for Bias in a Danish Population-Based Case-Control Study.

Authors:  Xin Cui; Zeyan Liew; Johnni Hansen; Pei-Chen Lee; Onyebuchi A Arah; Beate Ritz
Journal:  Neuroepidemiology       Date:  2019-01-18       Impact factor: 3.282

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.